(1,2,3-Triazol-4-yl)benzenamines: Synthesis and activity against VEGF receptors 1 and 2

Both synthesis and activity of the novel derivatives of (1,2,3-triazol-4-yl)benzenamines are described. Selected molecules of these series are potent and selective inhibitors of vascular endothelial growth factor receptors I and II (VEGFR-1/2).